2026 ACCP STEP & ESP Webinar: Exposure-Response Analysis Across the Drug Development Continuum: Foundational Principles

Live Session: Wednesday, March 11^th, 2026, from 1:00 to 2:00 PM ET

On Demand: March 11^th, 2026 to March 11^th, 2029

Target audience:

Interprofessional team of MDs, PharmDs, PhDs and other healthcare professionals who are interested in the foundational E-R principles and practical strategies that can be applied within regulatory, industry, and academic settings.

Objectives

After completing this activity, the learner will be able to:  

• Identify decisions to support, model influence, model risk and model impact;
• Discuss key considerations when creating a qualification plan for Exposure Response (E-R) analyses;
• Identify practical steps to guide the development of credible E-R models.

Description:

This webinar addresses gaps in foundational training on core Exposure–Response (E-R) principles relevant to drug development and clinical pharmacology practice. The presentation will explore practical steps to develop credible, fit-for-purpose E-R models aligned with best practices across the drug development continuum. Learners who complete this activity will enhance their knowledge of foundational E-R concepts, strengthening problem solving and critical thinking skills that can be directly applied to clinical pharmacology and regulatory decision-making settings.